Form 8-K - Current report:
SEC Accession No. 0001104659-19-062605
Filing Date
2019-11-12
Accepted
2019-11-12 16:03:55
Documents
3
Period of Report
2019-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922617d1_8k.htm 8-K 18321
2 EXHIBIT 99.1 tm1922617d1_ex99-1.htm EX-99.1 107571
3 GRAPHIC logo.gif GRAPHIC 2385
  Complete submission text file 0001104659-19-062605.txt   130331
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191209238
SIC: 2834 Pharmaceutical Preparations